跳至主要内容
临床试验/NCT07174024
NCT07174024已完成4 期

A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

Cairo University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年1月20日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Assess the degree of improvement in vitiligo pigmentation using VASI scores before and after treatment.

研究概览

简要总结

A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.

详细描述

A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •All age group.
  • •Both genders.
  • •Subjects with stable non-segmental vitiligo (≥2 patches) acral or non-acral patches of diameter ≤ 2cm.

排除标准

  • •Prior treatment with laser therapies for at least 3 months
  • •Recent exfoliation procedures.
  • •Recent surgical procedures.
  • •Poor skin conditions including keloids.
  • •Hypersensitivity to light ( visible and near-infrared).
  • •Medications that make users more sensitive to light.
  • •Anticoagulant and immunosuppressive treatments.
  • •Gestations or breastfeeding.
  • •A personal or family history of skin cancer.
  • •Unstable vitiligo (older lesions have not progressed for the last 1 years and lack of Koebner phenomena ).

研究组 & 干预措施

patients will receive NB-UVB phototherapy sessions on a Randomly selected patch

Active Comparator

patients will receive NB-UVB phototherapy sessions on a Randomly selected patch

干预措施: Narrow Band UVB Treatment (Device)

Patients will receive blue light emitting diodes phototherapy on a randomly selected patch

Active Comparator

Patients will receive blue light emitting diodes phototherapy on a randomly selected patch

干预措施: blue light emitting diode (Device)

结局指标

主要结局

Assess the degree of improvement in vitiligo pigmentation using VASI scores before and after treatment.

时间窗: 48 weeks

Assess the degree of improvement in vitiligo pigmentation using VASI scores before and after treatment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nahla Maher Mahmoud Mahran

Lecturer of Dermatology

Cairo University

研究点 (1)

Loading locations...

相似试验